Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Jan;93(1):35-37.
doi: 10.1002/jmv.26085. Epub 2020 Oct 30.

Elevated interleukin-6 is associated with severity of COVID-19: A meta-analysis

Jieyun Zhu  1 , Jielong Pang  1 , Pan Ji  1 , Zhimei Zhong  1 , Hongyuan Li  1 , Bocheng Li  1 , Jianfeng Zhang  1
Affiliations
Meta-Analysis

Elevated interleukin-6 is associated with severity of COVID-19: A meta-analysis

Jieyun Zhu et al. J Med Virol. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
Forest plot of weighted mean difference (WMD) and 95% confidence interval (95% CI) in interleukin‐6 levels between COVID‐19 patients
See this image and copyright information in PMC

References

    1. Wan S, Yi Q, Fan S, et al. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients. Br J Haematol. 2020;189:1‐24. 10.1111/bjh.16659 - DOI - PMC - PubMed
    1. Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID‐19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762‐768. 10.1093/cid/ciaa248 - DOI - PMC - PubMed
    1. Chen X, Zhao B, Qu Y, et al. Detectable serum SARS‐CoV‐2 viral load (RNAaemia)is closely correlated with drastically elevated interleukin 6 (IL‐6) level in critically ill COVID‐19 patients. Clin Infect Dis. 2020. 10.1093/cid/ciaa449 - DOI - PMC - PubMed
    1. Ulhaq ZS, Soraya GV. Interleukin‐6 as a potential biomarker of COVID‐19 progression. Med Mal Infect. 2020;20:79. 10.1016/j.medmal.2020.04.002 - DOI - PMC - PubMed
    1. Aziz M, Fatima R. Elevated interleukin‐6 and severe COVID‐19: a meta‐analysis. J Med Virol. 2020;92:2283‐2285. 10.1002/jmv.25948 - DOI - PMC - PubMed